Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Ranging Study of Cell-Derived H1N1 Vaccine in Adults
NCT00970177Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2009
- Primary completion
- Oct 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of Influenza A (H1N1) vaccine in pandemic influenza, sponsored by Novartis. Started Aug 2009; status: completed.
02
Drugs
Influenza A (H1N1) vaccine
03
Conditions
pandemic influenza
Beyond the preview
Go deeper on NCT00970177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00970177.